Vol. 17 No. 1 (2016)

Published: 2016-03-31

Editorial

Moving Center Stage: patients claim their role in healthcare

Anke-Peggy Holtorf, Neil Bertelsen

3-6
- HTML
- PDF

Original research

Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients

Umberto Restelli, Alfredo Alberti, Adriano Lazzarin, Marzia Bonfanti, Carmela Nappi, Davide Croce

7-12
- HTML
- PDF
Analysis of the treatment cost of HIV/AIDS in Turkey

Guvenc Kockaya, Tuba Elbir Zengin, Fatma Betul Yenilmez, Canan Dalgic, Simten Malhan Simten Malhan, Pamir Cerci, Ergun Oksuz, Serhat Unal

13-17
- HTML
- PDF
[Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy]

Sergio Iannazzo, Edoardo Mannucci, Lorenzo Mantovani

19-27
- HTML
- PDF
[Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]

Gianluca Furneri, Chiara Marchesi, Laura Santoni

29-39
- HTML
- PDF